does semaglutide increase insulin GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response How Does Semaglutide Work? Mechanism,

Does Mounjaro make you tired

Canadian Pharmacies Report GLP-1 Prices Range $300-570 Monthly Current pricing data from Canadian pharmacies shows significant variation in monthly costs for brand-name GLP-1 medications, with Ozempic and Wegovy ranging from $300 to $570 CAD per month depending on dose, pharmacy, and province

Look at the beyond-use date on the label

These include manufacturer savings cards, self-pay programs, and prescription discounts by pharmacies like GoodRx, BuzzRx, WellRx, Optum Perks, and SingleCare

Contact your GP or diabetes care team if you experience: Persistent or severe abdominal pain , particularly if localised to the upper abdomen or radiating to the back, which could indicate pancreatitis (a rare but serious adverse effect of GLP-1 receptor agonists) [3] [6] Right upper abdominal pain , with or without fever, jaundice (yellowing of skin/eyes), pale stools or dark urine, which may indicate gallbladder problems Intractable nausea and vomiting preventing adequate oral intake or medication adherence Signs of dehydration , including reduced urine output, dizziness, or dry mucous membranes Unexpected weight loss with poor intake or ongoing vomiting Difficulty swallowing or sensation of food getting stuck, which requires medical assessment Hypoglycaemia symptoms if using Ozempic with sulfonylureas or insulin, especially when food intake is reduced [1] [3] Seek immediate medical attention (call 999 or attend A&E) if you develop: Severe, persistent abdominal pain with or without vomiting, which may indicate acute pancreatitis Symptoms of allergic reaction , such as facial swelling, difficulty breathing, or widespread rash Severe dehydration with confusion, rapid heartbeat, or inability to keep down fluids Persistent vomiting with blood or coffee-ground appearance If pancreatitis is suspected, stop taking semaglutide and seek urgent medical assessment, as advised in the product information

GLP-1 medications arent one-size-fits-all